Mechanisms underlying the antifibrotic properties of noninhibitory PAI-1 (PAI-1R) in experimental nephritis.
about
Reciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosisPlasminogen activator inhibitor-1 is a transcriptional target of the canonical pathway of Wnt/beta-catenin signaling.Vitronectin accumulates in the interstitium but minimally impacts fibrogenesis in experimental chronic kidney diseaseVitronectin-binding PAI-1 protects against the development of cardiac fibrosis through interaction with fibroblastsThe vitronectin-binding function of PAI-1 exacerbates lung fibrosis in mice.A plasminogen activator inhibitor type 1 mutant retards diabetic nephropathy in db/db mice by protecting podocytesAbrogation of plasminogen activator inhibitor-1-vitronectin interaction ameliorates acute kidney injury in murine endotoxemia.Therapeutic potential of an orally effective small molecule inhibitor of plasminogen activator inhibitor for asthma.uPA binding to PAI-1 induces corneal myofibroblast differentiation on vitronectin.Therapeutic potential of plasminogen activator inhibitor-1 inhibitors.This is not Dr. Conn's aldosterone anymore.Challenging delivery of VLHL NS plasminogen activator inhibitor-1 by osmotic pumps in diabetic mouse: A case report.Plasminogen activator inhibitor-1 antisense oligodeoxynucleotides abrogate mesangial fibronectin accumulation.
P2860
Q26779846-E953D786-C96F-4045-9BE2-CA74FFECD0DCQ34042645-B0992BD7-BB13-40A6-9762-0955506C1338Q34979663-A1F7D715-D5C1-49DB-BDBC-3D4DD586677FQ35180538-5D35DCD6-9483-4C5E-AD84-74803BC82F9AQ35182731-9EC523EB-A8B4-4906-8737-DB44206E94CCQ35185276-F4BE8E72-1F2D-4333-ABE9-F66A6B664A20Q35584207-965488C8-92F0-4A86-82B0-4FCA9DC48170Q36583859-44C5AA6E-22A7-4F52-B078-27DE062C61D6Q37629834-AD02ED66-BA5B-4B29-86B6-938B5E5778F7Q37775818-97FD4AFE-CD19-4E47-9544-6F101B91F9F2Q37891697-7542D80D-4CAA-4D77-A5D6-77DADB3952B1Q41493665-E06EBD16-67AB-49F4-908B-71C37B21681BQ41966543-B57F204C-A02C-4BE3-8665-EAF8C83F08C7
P2860
Mechanisms underlying the antifibrotic properties of noninhibitory PAI-1 (PAI-1R) in experimental nephritis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mechanisms underlying the anti ...... 1R) in experimental nephritis.
@en
Mechanisms underlying the antifibrotic properties of noninhibitory PAI-1
@nl
type
label
Mechanisms underlying the anti ...... 1R) in experimental nephritis.
@en
Mechanisms underlying the antifibrotic properties of noninhibitory PAI-1
@nl
prefLabel
Mechanisms underlying the anti ...... 1R) in experimental nephritis.
@en
Mechanisms underlying the antifibrotic properties of noninhibitory PAI-1
@nl
P2093
P2860
P1476
Mechanisms underlying the anti ...... 1R) in experimental nephritis.
@en
P2093
Daniel A Lawrence
Nancy A Noble
Wayne A Border
Yufeng Huang
P2860
P304
P356
10.1152/AJPRENAL.00024.2009
P577
2009-07-22T00:00:00Z